Semaglutide for teens after weight-loss surgery
Part of Hormones & metabolism clinical trials.
This study looks at how teenagers and young adults respond to weight-loss surgery (sleeve gastrectomy) and whether adding a medication called semaglutide can help improve weight loss. It has two parts: first observing how surgery affects you, then testing if semaglutide helps those who didn't lose enough weight after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 12 to 24 years old
- You are planning to have a sleeve gastrectomy or have had one within the last 6 to 24 months
- If you already had surgery, you have not lost more than 22% of your body weight
- You do not have type 2 diabetes or certain other medical conditions like thyroid cancer or pancreatitis
- You are not using insulin or certain other weight-loss or diabetes medications now
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called semaglutide (a once-a-week injection) to help teenagers with autism who have obesity lose weight and improve their body composition. It compares their results to a group of similar teens who didn't take the drug.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.